Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Perrigo Acquires Rosemont Pharma | Contract Pharma

What are you searching for?

Sign in
Breaking News

Perrigo Acquires Rosemont Pharma

Expands liquid categories and Rx medicines, broadens market access

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Perrigo has completed the acquisition of Rosemont Pharmaceuticals, based in Leeds, UK, for approximately $283 million in cash. Rosemont is a specialty and generic pharmaceutical company focused on the manufacturing and marketing of oral liquid formulations, with a portfolio of more than 90 products. Rosemont’s sales were approximately $60 million in 2012.
 
Perrigo chairman, president and chief executive officer Joseph C. Papa said, “We continue to focus on expanding our international footprint and view the acquisition of Rosemont as an opportunistic next step given our existing presence in the UK. Similar to Perrigo’s position in the niche U.S. extended topical generic prescription market, Rosemont is the #1 player in the niche specialty U.K. oral liquid formulations market. We are excited to announce the acquisition of Rosemont and welcome its more than 200 employees to the Perrigo family. This transaction represents another step forward executing our strategy to make quality healthcare products more affordable for consumers around the world.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics